Next Article in Journal
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia
Next Article in Special Issue
In Vitro Analysis of Aerodynamic Properties and Co-Deposition of a Fixed-Dose Combination of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol Trifenatate
Previous Article in Journal
Role of In Vitro Tests in the Characterisation of Locally Applied, Locally Acting Drugs in the Throat: Application to Flurbiprofen
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(10), 1260; https://doi.org/10.3390/pharmaceutics16101260
Action Date Notes Link
article xml file uploaded 27 September 2024 15:39 CEST Original file -
article xml uploaded. 27 September 2024 15:39 CEST Update https://www.mdpi.com/1999-4923/16/10/1260/xml
article pdf uploaded. 27 September 2024 15:39 CEST Version of Record https://www.mdpi.com/1999-4923/16/10/1260/pdf
article html file updated 27 September 2024 15:40 CEST Original file -
article html file updated 27 June 2025 01:44 CEST Update https://www.mdpi.com/1999-4923/16/10/1260/html
Back to TopTop